Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells.
about
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftmentStereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells.Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease.Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model.Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients.SDF-1 chemokine signalling modulates the apoptotic responses to iron deprivation of clathrin-depleted DT40 cells.Design, Assessment, and in vivo Evaluation of a Computational Model Illustrating the Role of CAV1 in CD4(+) T-lymphocytes.Identification of miR-27b as a novel signature from the mRNA profiles of adipose-derived mesenchymal stem cells involved in the tolerogenic responseEnhanced activation of an amino-terminally truncated isoform of the voltage-gated proton channel HVCN1 enriched in malignant B cells.MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia.Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cellsIdentification of outcome-correlated cytokine clusters in chronic lymphocytic leukemiaHoming and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatmPARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alphaCXCR4 chemokine receptors, histone deacetylase inhibitors and acute lymphoblastic leukemia.A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia.JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemiaCross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survivalImpact of oxygen concentration on growth of mesenchymal stromal cells from the marrow of patients with chronic lymphocytic leukemia.The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target.Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".The microenvironment in mature B-cell malignancies: a target for new treatment strategiesNF-kappaB as a therapeutic target in chronic lymphocytic leukemia.The immunomodulatory properties of mesenchymal stem cells.The vascular niche: home for normal and malignant hematopoietic stem cells.Homeostatic chemokines guide lymphoma cells to tumor growth-promoting niches within secondary lymphoid organs.Chronic lymphocytic leukaemia--the role of the microenvironment pathogenesis and therapy.Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitizationMesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells.Modulation of B-cell receptor and microenvironment signaling by a guanine exchange factor in B-cell malignanciesInvolvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease.Functional proteomic insights in B-cell chronic lymphocytic leukemia.Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia.Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells.Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor.
P2860
Q30484167-14E66634-2CCF-4DED-9C50-E9D91B8AD7BAQ30994095-914BBC9A-EEA0-41CC-86B1-9D9D73DB03BFQ33809599-5B431385-1C3A-430A-9E9D-B262EAA130DDQ33862010-131F535B-1A0D-4AE7-85B8-D34F906E4947Q33934606-BD1B8A35-3296-4811-B55F-F5648E5ECF62Q34037828-888EF337-9DF1-4D0B-92E8-26EB899C4B00Q34097759-9A6A9C1E-4E8B-49CF-AE3C-B84D39B49F4CQ34637731-60BB755E-DDA6-4C5C-9512-36E8AD6F375EQ34683676-D19EF509-38AD-4664-B105-8DEC68F740FFQ34752063-8BDDF4B2-6379-4461-A6E1-45EE1305C4CCQ34836437-C1250FFE-4665-42DF-8711-16DABD19F45BQ35136736-AD10CA1E-2FF5-495C-ACB4-19D9C11FFA9DQ35553576-FD92BF8A-A4FB-45FC-837D-157C11207753Q35566338-591DEBDD-3AF3-49B3-9339-BF99C94762F7Q35843496-2EE85BFE-B236-412C-82A2-40C8452BA7EDQ35847913-4BB83B86-7398-4EE0-B7FD-146082ECF817Q36291260-0E180C33-2ADE-4091-A467-4D47321C6D28Q36384877-447ACD60-FD1A-4C19-919D-ADEF1B73B932Q36544062-3E334C2A-35A3-49CB-8745-81D858EDA108Q36561705-7C785CE5-1736-404C-9A47-B56A79C0B711Q36595313-BF34A76C-44E9-4525-A2BD-067DA4943487Q36800490-05251160-A0D3-4925-B8D3-7003CDDB0DA1Q36825701-A4F61F17-AAC5-472F-A839-0957EC23AD42Q37563816-B19F4909-4627-4D42-A72C-D5B19F740DF1Q37690750-CA18A01A-5617-48EC-BDF2-A60CEDC37E41Q37866167-1916D3B9-2858-417B-AA8D-60F86823CD6BQ37925467-34B2CDA4-60DC-4D4A-9A85-6D6443FA639FQ38009278-26A44EEC-D2A0-4E24-AE47-D7EE6A63CA87Q38101683-C30EB4E5-E4F4-4BF6-A950-B68021071682Q38132359-929EBFFF-BC2A-4379-A3D0-5AAD474138A7Q38310895-25457D16-E57E-41A6-A5CE-A92DB99073DEQ38736947-B3D65A28-E8E6-4DC0-979A-71CB70AF1A14Q38755788-8E6DD11D-A397-49F0-8C86-C94ACBF8DC21Q39017105-A73B43B9-C99F-45E2-81A7-32E2A056E70EQ39048554-66685FFA-CA79-4EEB-936A-F179FAB79C43Q39092611-CD0C622B-5E14-4FF2-B365-0D680F308AC3Q39215411-93C3C726-92BE-4EE5-8183-2203A0F99DD7Q39798268-72056582-34A7-4305-9DDF-F8846CC9E7C8Q39960316-4B27C918-6CA5-423F-A221-1BB2E69C1DF0Q41448224-1F0F8F03-4E7F-4872-8FA3-9D2285ECB58B
P2860
Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Chemokine receptors and stroma ...... lymphocytic leukemia B cells.
@ast
Chemokine receptors and stroma ...... lymphocytic leukemia B cells.
@en
Chemokine receptors and stroma ...... lymphocytic leukemia B cells.
@nl
type
label
Chemokine receptors and stroma ...... lymphocytic leukemia B cells.
@ast
Chemokine receptors and stroma ...... lymphocytic leukemia B cells.
@en
Chemokine receptors and stroma ...... lymphocytic leukemia B cells.
@nl
prefLabel
Chemokine receptors and stroma ...... lymphocytic leukemia B cells.
@ast
Chemokine receptors and stroma ...... lymphocytic leukemia B cells.
@en
Chemokine receptors and stroma ...... lymphocytic leukemia B cells.
@nl
P2860
P1433
P1476
Chemokine receptors and stroma ...... lymphocytic leukemia B cells.
@en
P2093
Jan A Burger
Thomas J Kipps
P2860
P304
P356
10.1080/10428190290011921
P577
2002-03-01T00:00:00Z